hotspot -WSS

hotspot

author：entertainment 2025-09-02 09:40:31 - browse：9

The Novartis booth at ESMO in Madrid. — The Novartis booth at ESMO 2023 in Madrid. Andrew Joseph/STAT

MADRID — Results presented Monday could expand the use of a Novartis therapy for metastatic prostate cancer, moving it from a treatment used after chemotherapy to one with demonstrated benefits beforehand as well.

The Phase 3 data, highlighted in a prime session here at the annual meeting of the European Society for Medical Oncology, also amount to another win for cancer therapies designed to deliver radiation directly to tumor cells. It’s a field that Novartis has poured investments into, and that is attracting interest from other pharma companies.

The trial, called PSMAfore, enrolled patients with a type of metastatic prostate cancer whose disease had started to progress after taking a drug known as an androgen receptor pathway inhibitor, or ARPI. Patients were randomized to either receive a different ARPI or Novartis’ therapy, Pluvicto.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： Novavax promises a turnaround & Lilly roils the obesity market
Next article： How dance can help nurses traumatized by Covid

focus

hotspot

WSS

Medicare to cover more brain scans for Alzheimer’s patients

Group opposing PBM reform sets lobbying record

Biogen’s boardroom scandal saddles CEO with first crisis

Biden tests positive for Covid

Indictment alleges Trump's ex

Key House panel plots a new health care package

Wikipedia

hotspot

entertainment

ChatGPT in medicine: STAT answers readers' burning questions

Why hospitals are withdrawing from US News rankings

Guidelines to prevent youth baseball injuries need more muscle

Health AI: on the border between health care and tech

Hepatitis C has a cure — but many Americans still lack access to it

Treatments for cramps don't cut it. Why aren't there better options?

Bright Health sells Medicare Advantage business to Molina

A public scorecard can help hold safety

Continuity nursing helped my family in our darkest PICU moments

Illumina slashes 2023 revenue projections yet again

knowledge

Judge sides with young activists in first

Cosmetics set for new safety regulation. Why the industry is on board

Surge in Apellis stock fueled by confidence in safety of its eye drug

Rescued Australian man who was adrift 3 months in Pacific with dog 'grateful' to be alive

Judge sides with young activists in first

A public scorecard can help hold safety

focus

hotspot

hotspot

knowledge